跳至主要内容
临床试验/JPRN-jRCTs051210200
JPRN-jRCTs051210200招募中3 期

Effectiveness of the enteral low-carbohydrate formula on post-gastrectomy hypoglycemia

Kubota Takeshi0 个研究点目标入组 30 人开始时间: 2022年3月22日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 <= 80age old(—)
性别
All

入选标准

  • 1)Patients who have obtained written informed consent for participation in the research.
  • 2)Men and women aged 20 to 80 at the time of informed consent acquisition.
  • 3)Patients who had been diagnosed with gastric cancer and 1-5 years have passed since they underwent gastrectomy (total gastrectomy and distal gastrectomy).
  • 4)Patients who have stable daily food intake and independent feeding behavior.
  • 5)Patients who understand the purpose of this study and can take the enteral low-carbohydrate formula by self-regulation.

排除标准

  • 1) Patients who have a history of abdominal surgery within 3 months.
  • 2)Patients who take the other nutritional supplement.
  • 3)Patients with galactosemia.
  • 4)Patients who have a history of hypersensitivity or diarrhea to the enteral low-carbohydrate formula.
  • 5)Patients who are being treated with insulin injections for type-1 or type-2 diabetes.
  • 6)Patients with poor glycemic control (HbA1c is 6.5% or higher, and/or casual blood glucose is 200mg/dL or higher).

研究者

发起方
Kubota Takeshi

相似试验

Effectiveness of the enteral low-carbohydrate... | 临床试验